Free Newsletter
88 drugs, vaccines filling HIV/AIDS pipeline
The FDA has approved more than 30 medicines to treat HIV/AIDS since the disease became widespread in the early 1980s. The life expectancy for many patients with the disease has increased considerably in that time. Without intervention, the average AIDS patient survives 9 to 11 years, and treatment with antiretroviral drugs can extend that to more than 20 years. But more effective medicines are still needed to prevent the spread of the disease. Of the 88 drugs in the HIV/AIDS pipeline (which include therapies in clinical testing or awaiting FDA approval), 49 are antivirals and 27 are vaccines, notes industry group PhRMA in a release. Article
More stories about AIDS vaccine
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
More Research Reports >>
SHARE
WITH: